Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon-γ release assay screening in biologics: safe and reliable, but not perfect.
Cafferkey J, Padayachee Y, Kostich S, Kumar K, Jewell P, Patel M, Chavda A, Cox A, Park M, Russell G, Coleman M, Martin L, Kon OM. Cafferkey J, et al. Among authors: cox a. ERJ Open Res. 2022 Nov 28;8(4):00193-2022. doi: 10.1183/23120541.00193-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36451845 Free PMC article.
WITHDRAWAL-Administrative Duplicate Publication: The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe.
Espina C, Bauld L, Bonanni B, Brenner H, Brown K, Dillner J, Kampman E, Nilbert M, Vineis P, Weijenberg MP, Cox A, de Kok TM, Fecht D, Mitrou G, Muller DC, Serrano D, Steindorf K, Storm H, Thorat MA, van Duijnhoven F, Weiderpass E, Schüz J. Espina C, et al. Among authors: cox a. Tumori. 2020 Oct;106(5):NP2-NP4. doi: 10.1177/0300891619851865. Epub 2019 May 17. Tumori. 2020. Retraction in: Tumori. 2020 Oct;106(5):433. doi: 10.1177/0300891619867815 PMID: 31099306 Free PMC article. Retracted. No abstract available.
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, Behrens S, Bermisheva M, de Gonzalez AB, Białkowska K, Boddicker N, Bodelon C, Bogdanova NV, Bojesen SE, Brantley KD, Brauch H, Brenner H, Camp NJ, Canzian F, Castelao JE, Cessna MH, Chang-Claude J, Chenevix-Trench G, Chung WK; NBCS Collaborators; Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dunning AM, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Fletcher O, Flyger H, Fritschi L, Gago-Dominguez M, Gentry-Maharaj A, González-Neira A, Guénel P, Hahnen E, Haiman CA, Hamann U, Hartikainen JM, Ho V, Hodge J, Hollestelle A, Honisch E, Hooning MJ, Hoppe R, Hopper JL, Howell S, Howell A; ABCTB Investigators; kConFab Investigators; Jakovchevska S, Jakubowska A, Jernström H, Johnson N, Kaaks R, Khusnutdinova EK, Kitahara CM, Koutros S, Kristensen VN, Lacey JV, Lambrechts D, Lejbkowicz F, Lindblom A, Lush M, Mannermaa A, Mavroudis D, Menon U, Murphy RA, Nevanlinna H, Obi N, Offit K, Park-Simon TW, Patel AV, Peng C, Peterlongo P, Pita G, Plaseska-Karanfilska D,… See abstract for full author list ➔ Yiangou K, et al. Among authors: cox a. Breast Cancer Res. 2024 Dec 29;26(1):189. doi: 10.1186/s13058-024-01947-x. Breast Cancer Res. 2024. PMID: 39734228 Free PMC article.
Adjuvant therapy with pembrolizumab in renal cell carcinoma: real-world experiences from a retrospective, multi-institutional cohort.
Mattigk A, Cano Garcia C, Klümper N, Cox A, Hahn O, Junker K, Erdmann K, Schmucker P, Flegar L, Zengerling F, Banek S, Ellinger J, Buerk BT, Huber J, Kalogirou C, Zeuschner P, Hoeh B. Mattigk A, et al. Among authors: cox a. Urol Int. 2024 Dec 24:1-21. doi: 10.1159/000543278. Online ahead of print. Urol Int. 2024. PMID: 39719131
The collaborative working group method for pre-trial knowledge mobilisation: a qualitative evaluation of a structured process for iteratively refining a complex intervention (DAFNEplus).
Breckenridge JP, Gossage-Worrall R, Chadwick P, De Zoysa N, Elliott J, Gianfrancesco C, Hamilton K, Heller S, Lawton J, Rankin D, Stanton-Fay S, Coates E; DAFNEplus Collaborative Working Group. Breckenridge JP, et al. Pilot Feasibility Stud. 2024 Dec 21;10(1):154. doi: 10.1186/s40814-024-01576-3. Pilot Feasibility Stud. 2024. PMID: 39709454 Free PMC article.
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron.
Sloop KW, Cox AL, Wainscott DB, White A, Droz BA, Stutsman C, Showalter AD, Suter TM, Dunbar JD, Snider BM, O'Farrell LS, Hewitt N, Ruble JC, Padgett LR, Woerly EM, Peterson JA, Coskun T, Liu Z, Coutant DE, Ai M, Emmerson PJ, Sangwung P, Willard FS. Sloop KW, et al. Among authors: cox al. Sci Transl Med. 2024 Dec 18;16(778):eadp5765. doi: 10.1126/scitranslmed.adp5765. Epub 2024 Dec 18. Sci Transl Med. 2024. PMID: 39693407
2,714 results